<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue journalpublishing.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">251</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of <italic>LOXL1</italic> polymorphisms in exfoliation syndrome in a Chinese population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Liyun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Ningli</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Guangxian</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chun</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Sujie</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wenru</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Meng</surname><given-names>Hailin</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Wotan</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ningpu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Huaizhou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Hongyan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology &#x00026; Visual Science Key Lab, Beijing, China</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, XingTai Eye Hospital, XingTai, China</aff><aff id="aff3"><label>3</label>Peking University Eye Center, Peking University Third Hospital, Beijing, China</aff><aff id="aff4"><label>4</label>Department of Ophthalmology, Handan Eye Hospital, Handan, China</aff><aff id="aff5"><label>5</label>Department of Ophthalmology, Anyang Eye Hospital, Anyang, China</aff><aff id="aff6"><label>6</label>Chinese National Human Genome Center, Beijing, China</aff></contrib-group><author-notes><fn><p>The first two authors contributed equally to this work</p></fn><corresp id="cor1">Correspondence to: Prof. Ningli Wang, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology &#x00026; Visual Science Key Lab, Beijing, China; Phone: (86) 58269920; FAX: (86) 58269920; email: <email xlink:href="wningli@vip.163.com">wningli@vip.163.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>14</day><month>11</month><year>2009</year></pub-date><volume>15</volume><fpage>2349</fpage><lpage>2357</lpage><history><date date-type="received"><day>03</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>01</day><month>11</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To evaluate the association profiles of the lysyl oxidase-like 1 (<italic>LOXL1</italic>) gene polymorphisms with exfoliation syndrome in a Chinese population.</p></sec><sec><title>Methods</title><p>Fifty unrelated patients with exfoliation syndrome and 125 control subjects were included. Genotypes of the three single nucleotide polymorphisms (SNPs) of <italic>LOXL1</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>) were analyzed by direct sequencing, and a case-control association study was performed.</p></sec><sec><title>Results</title><p>The three SNPs were significantly associated with exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) individually. After controlling for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, the association between <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and XFS/XFG remained significant (p=3.6&#x000d7;10<sup>-7</sup>). At this SNP, the T allele and TT genotype conferred a 7.59-(95% confidence interval [CI]: 3.87&#x02013;14.89, p=6.95&#x000d7;10<sup>-11</sup>) and 8.69-(95% CI: 4.15&#x02013;18.20, p&#x0003c;1.00&#x000d7;10<sup>-7</sup>) fold increased risk to the disease. The alleles of T at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and C at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were found to be risk alleles in Chinese subjects, which were opposite to Caucasian individuals. The haplotypes T-G, defined by SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and T-C by SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, were also significantly associated with the disorder. However when the genotypic or allelic frequencies of the three SNPs were compared between XFS and XFG, no significant difference was detected.</p></sec><sec><title>Conclusions</title><p><italic>LOXL1</italic> is a susceptibility gene of XFS/XFG in the Chinese population, and the association is mainly attributed to SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>. The risk alleles of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> in Chinese subjects were found to be opposite to that of Caucasians. The genotypic and allelic distributions of these SNPs are similar between XFS and XFG.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Wang</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Exfoliation syndrome (XFS) is an age-related disorder of the extracellular matrix in which abnormal fibrillar material is produced and progressively accumulated in tissues throughout the anterior segment and also in the connective tissues of various viscera. The clinical features of this disorder, which was initially described by Lindberg in 1917 [<xref ref-type="bibr" rid="r1">1</xref>], are deposition of white flake-like material on the anterior lens surface, the pupillary border, trabecular meshwork, zonula, ciliary body, and other anterior segment structures. XFS is a common identifiable cause for secondary glaucoma, i.e., exfoliation glaucoma (XFG), which is characterized by rapid progression, high resistance to medical therapy, and poor prognosis. XFS can not only lead to severe chronic open-angle glaucoma but also to acceleration of cataract formation, lens subluxation, angle closure glaucoma, and severe complications at the time of cataract extraction, such as zonular dialysis, capsular rupture, and vitreous loss [<xref ref-type="bibr" rid="r1">1</xref>&#x02013;<xref ref-type="bibr" rid="r4">4</xref>]. XFS is also a systemic disorder that is primarily related to vasculopathy, including transient ischemic attack, hypertension, angina, and myocardial infarction [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r4">4</xref>].</p><p>The prevalence of XFS varies greatly among ethnic groups, with a prevalence of 10&#x02013;20% among the elderly populations of Finland [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r6">6</xref>], Iceland [<xref ref-type="bibr" rid="r7">7</xref>], Sweden [<xref ref-type="bibr" rid="r8">8</xref>], and Greece [<xref ref-type="bibr" rid="r9">9</xref>], while being 0% in Greenland Eskimos [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>]. In Asian populations, the prevalence is relatively lower, being 3.01&#x02013;6.28% in Indians aged over 40 years [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>], 3.4% in Japanese aged over 50 years [<xref ref-type="bibr" rid="r14">14</xref>], 0.4% in Hong Kong Chinese aged over 60 years [<xref ref-type="bibr" rid="r15">15</xref>], and 0.2% and 0.7% in Singaporean Chinese aged over 40 and 60 years, respectively [<xref ref-type="bibr" rid="r16">16</xref>].</p><p>So far, the exact cause of the production of exfoliation material is still unknown, but there is evidence showing that genetic factors may play an important role in the pathogenesis of XFS [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r17">17</xref>&#x02013;<xref ref-type="bibr" rid="r23">23</xref>]. Ethnic differences in the prevalence of XFS, positive family history of XFS, increased risk for XFS in relatives [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r18">18</xref>&#x02013;<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r22">22</xref>], and twin studies [<xref ref-type="bibr" rid="r17">17</xref>] support the inheritance of XFS. Multiple inheritance patterns have been suggested, but no clear pattern is evident, implying that XFS is a complex disorder [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r23">23</xref>]. A genome-wide linkage study has reported a promising genetic locus on 18q as well as other potential loci [<xref ref-type="bibr" rid="r24">24</xref>].</p><p>Recently, a genome-wide association study in the Icelandic and Swedish populations indicated that three single nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (<italic>LOXL1</italic>) gene on chromosomal region 15q24 were significantly associated with XFS and XFG [<xref ref-type="bibr" rid="r25">25</xref>]. The three SNPs are <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> in the first intron and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in the first exon of the gene, which lead to substitution of amino acids at position 141 and 153, denoted as R141L and G153D, respectively [<xref ref-type="bibr" rid="r25">25</xref>]. LOXL1 is one of the five lysyl oxidase family members that catalyzes oxidative deamination of lysine residues of tropoelastin, which leads to the spontaneous cross-linking with consequential formation of elastin polymer fibers [<xref ref-type="bibr" rid="r25">25</xref>&#x02013;<xref ref-type="bibr" rid="r27">27</xref>]. Studies showed that <italic>LOXL</italic> knockout mice have diffuse connective tissue-associated changes secondary to failed elastic fiber homeostasis [<xref ref-type="bibr" rid="r27">27</xref>&#x02013;<xref ref-type="bibr" rid="r29">29</xref>]. XFS is proposed to arise from abnormal production and aggregation of elastin microfibrillar components produced by various cell types of the eye and other extraocular tissues [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r30">30</xref>]. Moreover, LOXL1 and elastin were found to be expressed in various ocular tissues, and <italic>LOXL1</italic> mRNA expression was differentially regulated dependent on the phase of progression of the fibrotic process and stages of XFS syndrome [<xref ref-type="bibr" rid="r30">30</xref>,<xref ref-type="bibr" rid="r31">31</xref>]. Therefore, the hypothesis that defects in <italic>LOXL1</italic> may cause XFS is biologically reasonable.</p><p>The association between XFS and the three <italic>LOXL1</italic> SNPs has been confirmed in other Caucasian [<xref ref-type="bibr" rid="r31">31</xref>&#x02013;<xref ref-type="bibr" rid="r38">38</xref>] and Indian populations [<xref ref-type="bibr" rid="r39">39</xref>]. In the Japanese population, the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> also showed association with XFS, but the risk alleles were opposite to the Caucasian study [<xref ref-type="bibr" rid="r40">40</xref>&#x02013;<xref ref-type="bibr" rid="r45">45</xref>]. So far, however, the role of these SNPs in XFS has rarely been studied in the Chinese population except one study in Singaporean Chinese in which <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was found to be associated with the disorder but no association was found for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> [<xref ref-type="bibr" rid="r46">46</xref>]. Therefore, this study was conducted to investigate the association between the <italic>LOXL1</italic> variants and XFS in the Chinese population.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study subjects</title><p>The diagnostic criterion for exfoliation syndrome is the existence of exfoliation material on the anterior lens capsule with dilation of the pupils or on the pupil margin in either eye. Patients with intraocular pressure (IOP) of less than 21 mmHg and no clinical evidence of glaucomatous optic neuropathy were classified as XFS. While exfoliation glaucoma (XFG) was diagnosed if the patient had the above characteristics of exfoliation syndrome and the following features: (1) IOP &#x02265;22 mmHg in either eye; (2) glaucomatous changes on the optic disc, defined as cup to disc ratio &#x0003e;0.7 in either eye or an asymmetric cup to disc ratio of &#x0003e;0.2 or notching of the disc rim; and (3) characteristic glaucomatous visual field loss [<xref ref-type="bibr" rid="r47">47</xref>]. Cases with other causes for secondary glaucoma, such as uveitis, pigment dispersion syndrome, and iridocorneal endothelial syndrome, were excluded. The patients were recruited from the following five hospitals, which were located in or near Beijing: Beijing Tongren Hospital, XingTai Eye Hospital, Peking University Third Hospital, Handan Eye Hospital, and Anyang Eye Hospital. Controls were individuals randomly selected from a population-based healthy entity in which 6830 people were recruited in a previous, comprehensive, ophthalmic, epidemiologic study in a county in north China near Beijing [<xref ref-type="bibr" rid="r48">48</xref>]. The controls were enrolled by the following criteria: (1) having no signs of XFS or XFG, (2) no glaucomatous changes on optic disc, (3) normal visual field and intraocular pressure, (4) no family history of glaucoma, and (5) no other eye diseases except mild refractive errors. As exfoliation syndrome is a late-onset disorder and rarely develops before the age of 50 years, only individuals aged 50 years or above were included into this study as controls. All study subjects were unrelated Han Chinese. They received comprehensive ophthalmic examinations, including visual acuity testing and refraction, Goldmann applanation tonometry, gonioscopy, slit lamp biomicroscopy in mydriasis, fundus examination, and automated static perimetry (Humphrey Visual Field Analyzer; Carl Zeiss Ophthalmic Systems, Inc. Humphrey Division, Dublin, CA). Peripheral venous blood was obtained from each subject.</p><p>The research protocol was approved by the ethics committee for human research of Beijing Tongren Hospital, Capital Medical University in Beijing, China. Informed consent was obtained from all participants after explaining the objective and nature of the study. The study was conducted in accordance with the Declaration of Helsinki.</p></sec><sec><title>Analysis of <italic>LOXL1</italic> polymorphisms</title><p>Genomic DNA was extracted from whole blood by using the Genomic DNA Extraction Kit, (Ebioshine Beijing Biotechnology Co., Ltd., Beijing, China). The three SNPs (rs1048661, rs3825942, and rs2165241) in the <italic>LOXL1</italic> gene, according to the previous report, were amplified by PCR and were directly sequenced [<xref ref-type="bibr" rid="r25">25</xref>]. Two sets of primers were used for amplification by PCR (<xref ref-type="table" rid="t1">Table 1</xref>). The PCR protocol was as follows: initial denaturation at 94 <sup>o</sup>C/5 min, followed by 10 cycles (94 <sup>o</sup>C/30 s, 65&#x02013;60 <sup>o</sup>C touchdown for 1 min with 0.5 <sup>o</sup>C decrement, 72 <sup>o</sup>C/45 s), 30 cycles (94 <sup>o</sup>C /30 s, 60 <sup>o</sup>C /1 min, 72 <sup>o</sup>C /45 s), and a final extension at 72 <sup>o</sup>C/1 min. Genotypes of the three <italic>LOXL1</italic> SNPs were determined by direct DNA sequencing, using BigDye Terminator v3.1 Kit (Applied Biosystems, Foster City, CA) in a 3730XL capillary sequencer (Applied Biosystems). The sequences were analyzed by Sequencing Analysis software v5.2 (Applied Biosystems).</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primer sequences for PCR for SNPs of <italic>LOXL1</italic>.</title></caption><table frame="hsides" rules="groups"><col width="141" span="1"/><col width="233" span="1"/><col width="55" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Amplicon</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequences</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Size (bp)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>&#x02028; and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>*<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02019;-CAACGGGCAGGTGTACAGCTT-3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">441<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02019;-GCGGGGTCGTAGTTCTCGTAC-3&#x02019;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: 5&#x02019;-CTCTAGGGCCCCTTGGAGAAT-3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">321<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">R: 5&#x02019;-GGCCAGAGGTCTGCTAAGCAC-3&#x02019;</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Two sets of primers were used for PCR for the three SNPs. The asterisk indicates that the same set of primer was used for rs1048661 and rs3825942.</p></table-wrap-foot></table-wrap></sec><sec><title>Statistical analysis</title><p>Hardy&#x02013;Weinberg equilibrium (HWE) was tested by using the &#x003c7;<sup>2</sup> test in SAS Genetics (v9.1, SAS Institute Inc., Cary, NC). The comparison of allelic and genotypic frequencies between case and control groups as well as haplotype association analysis was performed using a standard &#x003c7;<sup>2</sup> test with SAS Genetics. The Bonferroni method was used for the adjustment of multiple comparisons, with a p value of less than 0.017 (0.05/3) being considered as statistically different. Odds ratios (OR) with 95% confidence intervals (CI) were estimated by the SAS Genetics software and SPSS software (ver.12.0, SPSS inc., Chicago, IL). In order to exploit the major SNP that contribute to the association between <italic>LOXL1</italic> and the disorder, a conditional haplotype-based association test was performed using <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/plink/">PLINK</ext-link> (v1.06, Shaun Purcell) [<xref ref-type="bibr" rid="r49">49</xref>].</p><p>The SNP that has independent haplotyic effect and explains the omnibus association is considered as the predominant SNP. The allelic and genotypic association analysis as well as haplotype association analysis were also cross-checked with <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/plink/">PLINK</ext-link>. The allelic, genotypic and haplotype frequencies between two sub-phenotypes, i.e., XFS without glaucoma and XFG, were compared using the methods mentioned above. Pairwise linkage disequilibrium (LD) analysis among the three SNPs was performed in <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/haploview/haploview-downloads">Haploview</ext-link> (ver. 4.0, Daly Lab, Broad Institute, Cambridge, MA). The sensitivity (SE), specificity (SP), positive and negative predictive values (PPV and NPV) of the at-risk alleles, and genotypes for the three SNPs were calculated to evaluate their abilities of predicting the affection status using the adjusted estimation methods [<xref ref-type="bibr" rid="r50">50</xref>] ( the prevalence of XFS was estimated to be 0.2% [<xref ref-type="bibr" rid="r16">16</xref>]).</p></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 50 patients with exfoliation syndrome, including 43 cases with XFG and seven cases with XFS without glaucoma, as well as 125 control individuals were recruited into this study. The age at recruitment was 54&#x02013;87 years (mean age 70.4&#x000b1;7.6 years) in cases, 54&#x02013;80 years (mean age 63.8&#x000b1;5.1 years) in controls. The gender distribution between cases and controls was not significantly different (p=0.593), with 31 (62.0%) males and 19 (38.0%) females in cases and 72 (57.6%) males in controls. The IOP of the controls was 9&#x02013;20.25 mmHg (mean IOP 14.18&#x000b1;2.25 mmHg). The clinical features of the patients are shown in <xref ref-type="table" rid="t2">Table 2</xref>. Thirty out of the 43 XFG patients had severe glaucoma and had trabeculectomy more than once, and 20 cases were treated with medicine.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>The clinical features of the patients with XFS/XFG.</title></caption><table frame="hsides" rules="groups"><col width="173" span="1"/><col width="92" span="1"/><col width="103" span="1"/><col width="88" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><bold>Clinical features</bold></th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Total (n=50)</bold><hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>XFG (n=42)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>XFS with high IOP (n=1)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>XFS (n=7)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age at recruitment (mean &#x000b1; SD)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">70.20&#x000b1;7.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">73<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">71.28&#x000b1;8.94<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Range<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">(54-87)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">(73-73)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">(54-82)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gender (male/female)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28/14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1/0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2/5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">VCDR (mean &#x000b1; SD)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.78&#x000b1;0.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.40&#x000b1;0.08<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of trabeculectomy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=30<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of laser trabeculoplasty<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">History of laser iridotomy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">n=0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Treated with medicine</td><td valign="top" align="center" rowspan="1" colspan="1">n=19</td><td valign="top" align="center" rowspan="1" colspan="1">n=1</td><td valign="top" align="center" rowspan="1" colspan="1">n=0</td></tr></tbody></table><table-wrap-foot><p>A total of 50 patients with exfoliation syndrome were recruited into this study, including 43 cases with XFG and 7 cases with XFS without glaucoma. Thirty out of the 43 XFG patients had trabeculectomy for more than once and 20 cases were treated with medicine.</p></table-wrap-foot></table-wrap><p>Unequivocal genotypes of the three SNPs were obtained from both patients and controls. The genotype distribution of SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> deviated slightly from the HWE in controls (p=0.0245). SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> followed the HWE in controls (p=0.53 for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and p=0.21 for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, respectively). We further checked the reproducibility of genotyping of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> by re-performing DNA sequencing. The results were in complete agreement with that obtained the first time. Therefore, non-concordance with HWE for this SNP is not due to genotyping errors.</p><p>Allelic association analysis showed that there are significant differences in the allelic distributions between the two groups for the three SNPs (<xref ref-type="table" rid="t3">Table 3</xref>). The T allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was at a significantly higher frequency in cases than in controls (p=6.95&#x000d7;10<sup>-11</sup>, OR =7.59, 95% CI: 3.87&#x02013;14.89). SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was also associated with exfoliation syndrome (p=8.00&#x000d7;10<sup>-4</sup>), with the at-risk allele G presenting in 100% of patients. At <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, the frequency of the C allele was significantly higher in cases than in controls (p=1.10&#x000d7;10<sup>-2</sup>, OR=5.44, 95% CI: 1.27&#x02013;23.43). The genotypic frequencies for each of the three SNPs were also compared between cases and controls (<xref ref-type="table" rid="t3">Table 3</xref>). The frequency of genotype TT at SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was significantly higher in cases than in controls (p&#x0003c;1.00&#x000d7;10<sup>-7</sup>, OR=8.69, 95% CI: 4.15&#x02013;18.20), and the frequencies of GG and GT genotypes were significantly lower in cases than in controls. The genotypes of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was associated with exfoliation syndrome (p=3.84&#x000d7;10<sup>-3</sup>), with genotype GG being found in all patients, while GA and AA were detected only in controls. At rs2165421, only two genotypes, i.e., CC and CT, were detected. The genotype CC presented at a significantly higher frequency in cases than in controls (p=8.00&#x000d7;10<sup>-3</sup>), conferring approximately sixfold increased risks to exfoliation syndrome (OR=6.0, 95% CI: 1.37&#x02013;26.37). In the conditional haplotype-based association test, rs1048661 had an independent haplotypic effect after controlling for the other two SNPs (p=3.6&#x000d7;10<sup>-7</sup>), while <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> (p=0.0147) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> (p=0.498) did not have an independent haplotypic effect after controlling for the other two SNPs. Moreover, after controlling for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, the other two SNPs were no longer associated with the disorder (p=0.0462).</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Allele and genotype association analysis for the three SNPs of <italic>LOXL1</italic>.</title></caption><table frame="hsides" rules="groups"><col width="64" span="1"/><col width="119" span="1"/><col width="126" span="1"/><col width="48" span="1"/><col width="61" span="1"/><col width="110" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>XFS/XFG (n=50)</bold>&#x02028;<bold>Count (proportion)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control (n=125)</bold>&#x02028;<bold>Count (proportion)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>x<sup>2</sup></bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p value</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR (95%CI)</bold></th></tr></thead><tbody><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Allele<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89 (0.89)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">129 (0.52)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42.53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.95&#x000d7;10<sup>-11</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.59 (3.87-14.89)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11 (0.11)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">121 (0.48)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Genotype<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43 (0.86)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27 (0.22)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.69 (4.15-18.20)**<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3 (0.06)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75 (0.60)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4 (0.08)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23 (0.18)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43/3/4 (TT/GT/GG)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27/75/23 (TT/GT/GG)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.97&#x000d7;10<sup>-15</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Allele<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">100 (1.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">224 (0.90)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.00&#x000d7;10<sup>-4</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA*<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26 (0.10)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Genotype<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50 (1.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">101 (0.80)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.84&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA*<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22 (0.18)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 (0.02)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50/0/0 (GG/GA/AA)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">101/22/2 (GG/GA/AA)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.84&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Allele<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">98 (0.98)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">225 (0.90)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.44 (1.27-23.43)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 (0.02)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25 (0.10)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="6" valign="top" align="left" scope="col" rowspan="1">Genotype<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48 (0.96)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">100 (0.80)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.0 (1.37-26.37)**<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2 (0.04)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25 (0.20)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.00)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">48/2/0 (CC/CT/TT)</td><td valign="top" align="center" rowspan="1" colspan="1">100/25/0 (CC/CT/TT)</td><td valign="top" align="center" rowspan="1" colspan="1">7.01</td><td valign="top" align="center" rowspan="1" colspan="1">8.00&#x000d7;10<sup>-3</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>There were significant differences for the allelic proportion between case and control groups for all the three SNPs. T allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, G of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and C of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were risk alleles for the disorder. The genotypes TT for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, GG for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and CC for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were &#x0201c;risk&#x0201d; genotypes for the disease. Total indicate the general test of association in the 2-by-3 table of disease-by-genotype. NA: not available. The single asterisks indicate that all patients had G allele and genotype of GG for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, so the OR values couldn&#x02019;t be calculated. The double asterisks indicate the OR values and p values derived from comparision of the specific genotype with all the others, i.e., TT versus GT+GG at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, CC versus CT+TT at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>.</p></table-wrap-foot></table-wrap><p>Pairwise LD analysis showed that SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> were in strong LD (Coefficient of linkage disequilibrium [D&#x02019;] =1.000, LOD score [LOD] =6.96), SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were also in LD (D&#x02019;=0.913, LOD=5.14), but rs3825942 and rs2165241 were not in LD (D&#x02019;=0.007, LOD=0.00; <xref ref-type="fig" rid="f1">Figure 1</xref>). Pairwise SNPs with an LOD score of &#x0003e;3 were considered to be in LD [<xref ref-type="bibr" rid="r51">51</xref>].</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Analysis of linkage disequilibrium (LD) among the three SNPs of <italic>LOXL1</italic>. The SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were in strong LD, but <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were not in LD. The numbers &#x0201c;91&#x0201d; and &#x0201c;0&#x0201d; in the check indicate 100&#x000d7;D&#x02019; (D&#x02019; means coefficient of linkage disequilibrium).</p></caption><graphic xlink:href="mv-v15-2349-f1"/></fig><p>Haplotypes defined by the three SNPs were analyzed (<xref ref-type="table" rid="t4">Table 4</xref>). For the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, three haplotypes were observed. The haplotype T-G was identified to be significantly associated with exfoliation syndrome, conferring an approximately sevenfold increased risk to the disease (OR=6.77, 95% CI: 2.69&#x02013;17.03, p&#x0003c;1.00&#x000d7;10<sup>-3</sup>). The haplotype G-A was observed only in controls. For the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, four haplotypes were observed, among which the haplotype T-C was significantly associated with an increased susceptibility of XFS (OR=6.99, 95% CI: 2.78&#x02013;17.58, p&#x0003c;1.00&#x000d7;10<sup>-3</sup>). For the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, three haplotypes were observed, with the haplotype G-C being at a significantly higher frequency in cases than in controls (p=0.002, OR=12.18, 95% CI: 1.61&#x02013;92.09). The haplotype A-C was only observed in controls. The haplotypes for the three SNPs were also estimated. The haplotype T-G-C was at a significantly higher frequency in cases than in controls (p&#x0003c;1.00&#x000d7;10<sup>-3</sup>, OR=6.77, 95% CI: 2.69&#x02013;17.03). Besides, the haplotype T-G-T was observed only in cases, while the haplotypes G-A-C and G-A-T were observed in controls exclusively.</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Haplotype Association analysis between the <italic>LOXL1</italic> SNPs and XFS/XFG</title></caption><table frame="hsides" rules="groups"><col width="61" span="1"/><col width="61" span="1"/><col width="61" span="1"/><col width="62" span="1"/><col width="50" span="1"/><col width="37" span="1"/><col width="69" span="1"/><col width="120" span="1"/><thead><tr><th rowspan="2" colspan="3" valign="top" align="center" scope="colgroup">Haplotype</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Proportion<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">x<sup>2</sup></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">p value</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">OR (95%CI)</th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Case</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link><hr/></td><td colspan="6" valign="top" align="left" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.09<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.77 (2.69 - 17.03)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.38<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.67<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.22 (0.09 - 0.55)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.104<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.21<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.36<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td><td colspan="6" valign="top" align="left" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.99 (2.78 - 17.58)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.08 (0.01 - 0.62 )<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.112<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.384<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.64<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.18 (0.07 - 0.48)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.70<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.002<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.18 (1.61 - 92.09)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.163<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.159<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.002<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.001(0 - inf)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.45<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td><td colspan="5" valign="top" align="left" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.70<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.77 (2.69 - 17.03)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.29<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.28 (0.10 - 0.75)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.09<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.108<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.113<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.094<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.052<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.526<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA *<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">20.37</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;1.00&#x000d7;10<sup>-3</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>The haplotypes T-G, T-C and G-C for the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were identified to be significantly associated with XFS, respectively. The haplotype T-G-C for the three SNPs was identified to be significantly associated with XFS. Total indicate omnibus tests, while the others indicate the haplotype-specific tests. The OR values were obtained from comparision of each individual haplotype with all the other haplotypes, i.e., T-G versus G-G + G-A for the SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, et al. NA: not available. The asterisks indicate that the OR values were not available since differences between cases and controls were not significant for these haplotypes (p&#x0003e;0.017).</p></table-wrap-foot></table-wrap><p>The at-risk alleles and genotypes of the three SNPs were analyzed for their abilities to predict the affection status (<xref ref-type="table" rid="t5">Table 5</xref>). High SE (87.7%, 95% CI: 78.6&#x02013;96.8%) but low SP (19.8%, 95% CI: 12.8&#x02013;26.8%) was found for the T allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>. The TT genotype of this SNP was with increased SP (77.1%, 95% CI: 69.7&#x02013;84.5%) and high SE (82.3%, 95% CI: 71.7&#x02013;92.9%). Although the NPVs were high, the PPVs were low for the risk alleles and genotypes of all three SNPs.</p><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>The sensitivity, specificity, positive and negative predictive values for the risk alleles and genotypes of the three SNPs of <italic>LOXL1</italic>.</title></caption><table frame="hsides" rules="groups"><col width="84" span="1"/><col width="103" span="1"/><col width="103" span="1"/><col width="121" span="1"/><col width="121" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SE (95%CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SP (95%CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>PPV (95%CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>NPV (95%CI)</bold></th></tr></thead><tbody><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">allele (T)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.877(0.786-0.968)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.198(0.128-0.268)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0022(0.0019-0.0025)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9988(0.9988-1.00)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">genotype (TT)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.823(0.717-0.929)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.771(0.697-0.845)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0072(0.0047-0.0097)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9995(0.9992-0.9998)<hr/></td></tr><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">allele (G)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.948(0.886-1.00)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.037(0.004-0.070)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0020(0.0019-0.0021)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9972(0.9930-1.00)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">genotype (GG)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.948(0.886-1.00)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.206(0.135-0.277)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0024(0.0021-0.0027)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9995(0.9989-1.00)<hr/></td></tr><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">allele (C)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.948(0.886-1.00)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.022(0.004-0.048)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0019(0.0017-0.0020)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9953(0.9875-1.00)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">genotype (CC)</td><td valign="top" align="left" rowspan="1" colspan="1">0.912(0.833-0.991)</td><td valign="top" align="left" rowspan="1" colspan="1">0.213(0.141-0.285)</td><td valign="top" align="left" rowspan="1" colspan="1">0.0023(0.0020-0.0026)</td><td valign="top" align="left" rowspan="1" colspan="1">0.9992(0.9984-1.00)</td></tr></tbody></table><table-wrap-foot><p>SE, SP, PPV and NPV indicate sensitivity, specificity, positive and negative predictive values, respectively. High SE (82.3%) and high SP (77.1%) were found at the TT genotype of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>.</p></table-wrap-foot></table-wrap><p>The allelic, genotypic, and haplotypic frequencies of the three SNPs between the two sub-phenotypes, i.e., XFS without glaucoma and XFG, were not significantly different (p&#x0003e;0.05, data not shown).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The association between the <italic>LOXL1</italic> gene and XFS/XFG in the Chinese population has rarely been reported except in one recent report from Singapore [<xref ref-type="bibr" rid="r46">46</xref>]. In this present study, three major <italic>LOXL1</italic> SNPs were found to be significantly associated with XFS/XFG, even though the sample size was as small as 50. Hence, the effect sizes of these SNPs in the Chinese populaton were large, and 50 samples provided a good statistical power to detect significant association. In the Chinese population, however, it is usually difficult to recruit a large sample of XFS/XFG because of the low disease prevalence (0.2&#x02013;0.7%) in this ethnic group [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>]. The reason for the low prevalence in Chinese individuals is still unknown. Similarly, the prevalence of this disorder is also relatively low in Japanese and other Asian populations compared with the Caucasian populations [<xref ref-type="bibr" rid="r12">12</xref>&#x02013;<xref ref-type="bibr" rid="r14">14</xref>]. Such a discrepancy in disease prevalence might not be fully explained by the ethnic difference in the frequencies of the at-risk alleles at the <italic>LOXL1</italic> SNPs (<xref ref-type="table" rid="t6">Table 6</xref>). Hence, other genetic and/or environmental factors, yet to be identified, might be involved in the development of the disorder.</p><table-wrap id="t6" position="float"><label>Table 6</label><caption><title>Risk alleles and MAF for the three SNPs of <italic>LOXL1</italic> in different populations.</title></caption><table frame="hsides" rules="groups"><col width="110" span="1"/><col width="73" span="1"/><col width="66" span="1"/><col width="69" span="1"/><col width="59" span="1"/><col width="63" span="1"/><col width="59" span="1"/><col width="90" span="1"/><thead><tr><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Population</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>&#x02028;<bold> (G/T)</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>&#x02028;<bold> (G/A)</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>&#x02028;<bold> (T/C)</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Reference</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>Risk allele</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>MAF</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Risk allele</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>MAF</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Risk allele</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>MAF</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Iceland<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.349 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.153 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.473 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r25">25</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Sweden<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.318 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.121 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.465 (C)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Austria<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.329 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.183 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r36">36</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">United States<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.335 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.156 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.487 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r34">34</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">United States<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.297 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.202 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.448 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r32">32</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">United States<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.400 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.120 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r33">33</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">United States<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.281 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.205 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.456 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r35">35</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Germany and Italy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.348 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.149 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.488 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r37">37</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Australia<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r31">31</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">refSNP (European)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.040 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.172 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.392(T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NCBI Database<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">India<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">*<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.270 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.070 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r39">39</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.450 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.147 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r41">41</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.497 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.137 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.102 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r43">43</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.460 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.143 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r40">40</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r45">45</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.493 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.123 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r42">42</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Japan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.450 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.194 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.124 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r44">44</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Singapore (Chinese)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">*<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.444 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.082 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r46">46</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">China (Beijing)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.484 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.104 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.100 (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">present study<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">China<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r52">52</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">(Hongkong)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.470 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.124 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.102 (T)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">(Beijing)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.497 (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.135 (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.084 (T)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">refSNP<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NCBI Database<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Asian (China)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.111(T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.067 (T)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Asian (Japan)</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">0.438 (G)</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">0.125 (T)</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">0.167 (T)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>NA indicates not available. The asterisk indicates that no association was found. MAF indicates minor allele frequency.</p></table-wrap-foot></table-wrap><p>In this present study, the association between the three <italic>LOXL1</italic> SNPs and XFS /XFG has been replicated in the Chinese cases. However, like the findings reported from the Japanese population [<xref ref-type="bibr" rid="r40">40</xref>&#x02013;<xref ref-type="bibr" rid="r45">45</xref>], the risk alleles at SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were different from that in Caucasian populations, as shown in <xref ref-type="table" rid="t6">Table 6</xref>. The risk allele T at SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was found to confer a 7.6-fold increased risk to XFS/XFG (95% CI: 3.87&#x02013;14.89, p=6.95&#x000d7;10<sup>-11</sup>), while the homozygous genotype TT was found to have an even larger effect size, with an OR of 8.69 (95% CI: 4.15&#x02013;18.20, p&#x0003c;1.00&#x000d7;10<sup>-7</sup>). The reasons for the discrepancy in the genotypic distributions of this SNP among XFS/XFG patients with different ethnicities remain unknown. Conditional haplotype-based association test showed that <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> had independent haplotyic effect (p=3.6&#x000d7;10<sup>-7</sup>), and the association between the other two SNPs and the disorder was no longer significant after controlling for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> (p=0.0462), suggesting that this SNP is the major SNP contributing to the association. Moreover, in one study in an Indian population and one study in a Singaporean Chinese population, no association was found for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> with the disorder [<xref ref-type="bibr" rid="r39">39</xref>,<xref ref-type="bibr" rid="r46">46</xref>]. In an American study, the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> was not associated with the disorder after controlling the other two SNPs [<xref ref-type="bibr" rid="r35">35</xref>]. These findings suggest that there are other yet-to-be-identified modifier factors (environmental or genetic) among different populations involved in the pathogenesis of XFS/XFG. Since the association profiles of <italic>LOXL1</italic> and XFS/XFG were distinctively different between Beijing Chinese and Singaporean Chinese cases [<xref ref-type="bibr" rid="r46">46</xref>], further investigations of this association from multiple centers are needed to unravel the role of <italic>LOXL1</italic> in the genetics of XFS/XFG among the Chinese population.</p><p>The SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> is located in the first exon of the <italic>LOXL1</italic> gene and leads to a substitution of amino acids at position 141 [<xref ref-type="bibr" rid="r25">25</xref>]. The effect of such a substitution on <italic>LOXL1</italic> mRNA expression has been investigated in order to provide clues on the role of this SNP in the pathogenesis of XFS/XFG. Thorleifsson and colleagues observed a decrease of 7.7% in <italic>LOXL1</italic> mRNA expression in adipose tissue of Caucasian patients with the G allele [<xref ref-type="bibr" rid="r25">25</xref>], whereas Kazuhiko and colleagues did not observe any change of <italic>LOXL1</italic> mRNA expression in lens capsule from Japanese XFG patients [<xref ref-type="bibr" rid="r45">45</xref>]. On the other hand, irrespective of individual genotype, ocular <italic>LOXL1</italic> expression was found to be differentially regulated in different stages of the disorder. The <italic>LOXL1</italic> mRNA expression was upregulated in the early stage but was decreased in an advanced stage [<xref ref-type="bibr" rid="r30">30</xref>]. Further studies are needed to clarify the role of this SNP in the expression of <italic>LOXL1</italic> and subsequently in the pathogenesis of this disorder.</p><p>Besides <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> were also significantly associated with XFS/XFG individually. However, when controlled for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, the association became insignificant, suggesting they are more likely to be genetic markers in LD with the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>. The <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> was associated with the disorder in Caucasians [<xref ref-type="bibr" rid="r25">25</xref>,<xref ref-type="bibr" rid="r35">35</xref>] and Japanese [<xref ref-type="bibr" rid="r43">43</xref>]. However, this SNP has no functional impact on the <italic>LOXL1</italic> mRNA level in adipose tissue [<xref ref-type="bibr" rid="r25">25</xref>] or anterior lens capsule [<xref ref-type="bibr" rid="r45">45</xref>]. Concerning the SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link>, which is located in the intronic region, the functional impact of this SNP remains unknown. Similar to SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>, the association profile of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> resembles that in a Japanese population [<xref ref-type="bibr" rid="r43">43</xref>,<xref ref-type="bibr" rid="r44">44</xref>] but was opposite to the Caucasians [<xref ref-type="bibr" rid="r25">25</xref>,<xref ref-type="bibr" rid="r34">34</xref>].</p><p>In this present study, although the sample size of XFS without glaucoma was small (n=7), the allelic and genotypic frequencies of the three SNPs in the two sub-phenotypes were similar and had no statistical significance. This finding is consistent with other studies [<xref ref-type="bibr" rid="r25">25</xref>]. The <italic>LOXL1</italic> gene is more likely a susceptibility gene for XFS rather than a triggering factor for the development of XFG, and there may be other genetic or environmental factors predisposing individuals toward XFG.</p><p>High SE and SP for the risk genotype TT at SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> (82.3%, 95% CI: 71.7&#x02013;92.9% and 77.1%, 95% CI: 69.7&#x02013;84.5%) imply the potential value of the diagnostic test for XFS, although further studies are needed. However applying genotyping of the SNPs was inappropriate in screening patients with XFS among this Chinese population due to low PPVs (<xref ref-type="table" rid="t5">Table 5</xref>).</p><p>In summary, we confirmed the results that the three SNPs of <italic>LOXL1</italic> are associated with XFS/XFG, but the risk alleles at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241">rs2165241</ext-link> in this present study are opposite to Caucasian populations. The <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> is the predominant SNP associated with XFS/XFG in our study cohort. The role of this SNP in pathogenesis of the disorder needs to be studied further, and further investigations are also needed to unravel additional genetic or environmental factors modifying the development of this disorder.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank all the patients and healthy participants in this study. We are also indebted to Dr Lijia Chen and Prof CP Pang for their critical reviews of the manuscript.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Konstas</surname><given-names>AG</given-names></name></person-group><article-title>Why is glaucoma associated with exfoliation syndrome?</article-title><source>Prog Retin Eye Res</source><year>2003</year><volume>22</volume><fpage>253</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12852486</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naumann</surname><given-names>GO</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Kuchle</surname><given-names>M</given-names></name></person-group><article-title>Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.</article-title><source>Ophthalmology</source><year>1998</year><volume>105</volume><fpage>951</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">9627642</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesti</surname><given-names>E</given-names></name><name><surname>Kivel</surname><given-names>AT</given-names></name></person-group><article-title>Exfoliation syndrome and exfoliation glaucoma.</article-title><source>Prog Retin Eye Res</source><year>2000</year><volume>19</volume><fpage>345</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">10749381</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name></person-group><article-title>Exfoliation syndrome.</article-title><source>Surv Ophthalmol</source><year>2001</year><volume>45</volume><fpage>265</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">11166342</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirvela</surname><given-names>H</given-names></name><name><surname>Luukinen</surname><given-names>H</given-names></name><name><surname>Laatikainen</surname><given-names>L</given-names></name></person-group><article-title>Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study.</article-title><source>Ophthalmology</source><year>1995</year><volume>102</volume><fpage>108</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">7831024</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsman</surname><given-names>E</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Lu</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>A</given-names></name><name><surname>Fellman</surname><given-names>J</given-names></name><name><surname>Jarvela</surname><given-names>I</given-names></name><name><surname>Forsius</surname><given-names>H</given-names></name></person-group><article-title>Exfoliation syndrome: prevalence and inheritance in a subisolate of the Finnish population.</article-title><source>Acta Ophthalmol Scand</source><year>2007</year><volume>85</volume><fpage>500</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17655611</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Sverrisson</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name></person-group><article-title>Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study.</article-title><source>Eye</source><year>2003</year><volume>17</volume><fpage>747</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12928689</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astrom</surname><given-names>S</given-names></name><name><surname>Linden</surname><given-names>C</given-names></name></person-group><article-title>Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report.</article-title><source>Acta Ophthalmol Scand</source><year>2007</year><volume>85</volume><fpage>828</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">17986290</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozobolis</surname><given-names>VP</given-names></name><name><surname>Papatzanaki</surname><given-names>M</given-names></name><name><surname>Vlachonikolis</surname><given-names>IG</given-names></name><name><surname>Pallikaris</surname><given-names>IG</given-names></name><name><surname>Tsambarlakis</surname><given-names>IG</given-names></name></person-group><article-title>Epidemiology of pseudoexfoliation in the island of Crete (Greece).</article-title><source>Acta Ophthalmol Scand</source><year>1997</year><volume>75</volume><fpage>726</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9527341</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challa</surname><given-names>P</given-names></name></person-group><article-title>Genetics of pseudoexfoliation syndrome.</article-title><source>Curr Opin Ophthalmol</source><year>2009</year><volume>20</volume><fpage>88</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19240540</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lantukh</surname><given-names>VV</given-names></name><name><surname>Piatin</surname><given-names>MM</given-names></name></person-group><comment/><article-title>Features of ocular pathology among the indigenous inhabitants of Chukotka.</article-title><source>Vestn Oftalmol</source><year>1982</year><issue>4</issue><fpage>18</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">7135721</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnadas</surname><given-names>R</given-names></name><name><surname>Nirmalan</surname><given-names>PK</given-names></name><name><surname>Ramakrishnan</surname><given-names>R</given-names></name><name><surname>Thulasiraj</surname><given-names>RD</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Tielsch</surname><given-names>JM</given-names></name><name><surname>Friedman</surname><given-names>DS</given-names></name><name><surname>Robin</surname><given-names>AL</given-names></name></person-group><article-title>Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey.</article-title><source>Am J Ophthalmol</source><year>2003</year><volume>135</volume><fpage>830</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12788123</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Nirmalan</surname><given-names>PK</given-names></name><name><surname>Krishnaiah</surname><given-names>S</given-names></name></person-group><article-title>Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>1170</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15790875</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Kiyohara</surname><given-names>Y</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Nose</surname><given-names>Y</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name></person-group><article-title>The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study.</article-title><source>J Glaucoma</source><year>2005</year><volume>14</volume><fpage>482</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16276281</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AL</given-names></name><name><surname>Tang</surname><given-names>WW</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name></person-group><article-title>The prevalence of pseudoexfoliation syndrome in Chinese people.</article-title><source>Br J Ophthalmol</source><year>2004</year><volume>88</volume><fpage>193</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14736771</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>PJ</given-names></name><name><surname>Seah</surname><given-names>SK</given-names></name></person-group><article-title>The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey.</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>239</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15665360</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottfredsdottir</surname><given-names>MS</given-names></name><name><surname>Sverrisson</surname><given-names>T</given-names></name><name><surname>Musch</surname><given-names>DC</given-names></name><name><surname>Stefansson</surname><given-names>E</given-names></name></person-group><article-title>Chronic open-angle glaucoma and associated ophthalmic findings in monozygotic twins and their spouses in Iceland.</article-title><source>J Glaucoma</source><year>1999</year><volume>8</volume><fpage>134</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10209731</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>C</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Vieira</surname><given-names>G</given-names></name><name><surname>Liebmann</surname><given-names>J</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name></person-group><article-title>Early diagnosis of exfoliation syndrome in the offspring of affected patients.</article-title><source>Acta Ophthalmol Scand</source><year>2006</year><volume>84</volume><fpage>512</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16879573</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Bains</surname><given-names>HS</given-names></name><name><surname>Amjadi</surname><given-names>K</given-names></name><name><surname>Dohadwala</surname><given-names>AA</given-names></name><name><surname>Valberg</surname><given-names>JD</given-names></name><name><surname>Chevrier</surname><given-names>R</given-names></name><name><surname>Gould</surname><given-names>LF</given-names></name><name><surname>Zackon</surname><given-names>DH</given-names></name><name><surname>Addison</surname><given-names>DJ</given-names></name></person-group><article-title>Familial occurrence of pseudoexfoliation in Canada.</article-title><source>Can J Ophthalmol</source><year>1999</year><volume>34</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">10486684</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>JG</given-names></name><name><surname>Mercieca</surname><given-names>F</given-names></name><name><surname>Fenech</surname><given-names>T</given-names></name><name><surname>Cuschieri</surname><given-names>A</given-names></name></person-group><article-title>Familial pseudoexfoliation in Gozo.</article-title><source>Eye</source><year>2005</year><volume>19</volume><fpage>1280</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15565186</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allingham</surname><given-names>RR</given-names></name><name><surname>Loftsdottir</surname><given-names>M</given-names></name><name><surname>Gottfredsdottir</surname><given-names>MS</given-names></name><name><surname>Thorgeirsson</surname><given-names>E</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Sverisson</surname><given-names>T</given-names></name><name><surname>Hodge</surname><given-names>WG</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Stefansson</surname><given-names>E</given-names></name></person-group><article-title>Pseudoexfoliation syndrome in Icelandic families.</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><fpage>702</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11371492</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>AC</given-names></name><name><surname>Robitaille</surname><given-names>JM</given-names></name><name><surname>Price</surname><given-names>PA</given-names></name><name><surname>Hamilton</surname><given-names>JR</given-names></name><name><surname>Falvey</surname><given-names>DM</given-names></name><name><surname>De Saint-Sardos</surname><given-names>AG</given-names></name><name><surname>Pasternak</surname><given-names>S</given-names></name><name><surname>Guernsey</surname><given-names>DL</given-names></name></person-group><article-title>Exfoliation syndrome: clinical and genetic features.</article-title><source>Ophthalmic Genet</source><year>2001</year><volume>22</volume><fpage>171</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">11559859</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Bains</surname><given-names>HS</given-names></name><name><surname>Stefansson</surname><given-names>E</given-names></name><name><surname>Loftsdottir</surname><given-names>M</given-names></name><name><surname>Sverrisson</surname><given-names>T</given-names></name><name><surname>Thorgeirsson</surname><given-names>E</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Gottfredsdottir</surname><given-names>M</given-names></name><name><surname>Allingham</surname><given-names>RR</given-names></name></person-group><article-title>Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation.</article-title><source>Ophthalmic Genet</source><year>1998</year><volume>19</volume><fpage>175</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">9895242</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmela</surname><given-names>S</given-names></name><name><surname>Forsman</surname><given-names>E</given-names></name><name><surname>Sistonen</surname><given-names>P</given-names></name><name><surname>Eriksson</surname><given-names>A</given-names></name><name><surname>Forsius</surname><given-names>H</given-names></name><name><surname>Jarvela</surname><given-names>I</given-names></name></person-group><article-title>Genome-wide scan of exfoliation syndrome.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>4136</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17724198</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Stefansdottir</surname><given-names>G</given-names></name><name><surname>Masson</surname><given-names>G</given-names></name><name><surname>Hardarson</surname><given-names>GA</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Motallebipour</surname><given-names>M</given-names></name><name><surname>Wallerman</surname><given-names>O</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>1397</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">17690259</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname><given-names>HM</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell.</article-title><source>J Cell Biochem</source><year>2003</year><volume>88</volume><fpage>660</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12577300</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Pawlyk</surname><given-names>B</given-names></name><name><surname>Starcher</surname><given-names>B</given-names></name><name><surname>Spencer</surname><given-names>JA</given-names></name><name><surname>Yanagisawa</surname><given-names>H</given-names></name><name><surname>Zuo</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>178</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">14745449</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Pawlyk</surname><given-names>B</given-names></name><name><surname>Damaser</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>Failure of elastic fiber homeostasis leads to pelvic floor disorders.</article-title><source>Am J Pathol</source><year>2006</year><volume>168</volume><fpage>519</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">16436666</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>RK</given-names></name></person-group><article-title>The molecular pathophysiology of pseudoexfoliation glaucoma.</article-title><source>Curr Opin Ophthalmol</source><year>2008</year><volume>19</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">18301281</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name></person-group><article-title>Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.</article-title><source>Exp Eye Res</source><year>2009</year><volume>88</volume><fpage>776</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">18809397</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Burdon</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name><name><surname>Dimasi</surname><given-names>DP</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name></person-group><article-title>Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>710</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18037624</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragon-Martin</surname><given-names>JA</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Liebmann</surname><given-names>J</given-names></name><name><surname>O'Brien</surname><given-names>C</given-names></name><name><surname>Blaaow</surname><given-names>K</given-names></name><name><surname>Mercieca</surname><given-names>F</given-names></name><name><surname>Spiteri</surname><given-names>A</given-names></name><name><surname>Cobb</surname><given-names>CJ</given-names></name><name><surname>Damji</surname><given-names>KF</given-names></name><name><surname>Tarkkanen</surname><given-names>A</given-names></name><name><surname>Rezaie</surname><given-names>T</given-names></name><name><surname>Child</surname><given-names>AH</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>533</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18385788</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Streb</surname><given-names>LM</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>974</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18036875</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challa</surname><given-names>P</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Vann</surname><given-names>RR</given-names></name><name><surname>Gonzalez</surname><given-names>P</given-names></name><name><surname>Allingham</surname><given-names>RR</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name></person-group><article-title>Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>146</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18334928</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>BJ</given-names></name><name><surname>Pasquale</surname><given-names>L</given-names></name><name><surname>Grosskreutz</surname><given-names>CL</given-names></name><name><surname>Rhee</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>DeAngelis</surname><given-names>MM</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>del Bono</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Wiggs</surname><given-names>JL</given-names></name></person-group><article-title>DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">18254956</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossbock</surname><given-names>G</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Faschinger</surname><given-names>C</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Wedrich</surname><given-names>A</given-names></name><name><surname>Weger</surname><given-names>M</given-names></name></person-group><article-title>Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>857</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18483563</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasutto</surname><given-names>F</given-names></name><name><surname>Krumbiegel</surname><given-names>M</given-names></name><name><surname>Mardin</surname><given-names>CY</given-names></name><name><surname>Paoli</surname><given-names>D</given-names></name><name><surname>Lammer</surname><given-names>R</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name><name><surname>Kruse</surname><given-names>FE</given-names></name><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name></person-group><article-title>Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>1459</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">18385063</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmela</surname><given-names>S</given-names></name><name><surname>Forsman</surname><given-names>E</given-names></name><name><surname>Onkamo</surname><given-names>P</given-names></name><name><surname>Nurmi</surname><given-names>H</given-names></name><name><surname>Laivuori</surname><given-names>H</given-names></name><name><surname>Kivela</surname><given-names>T</given-names></name><name><surname>Puska</surname><given-names>P</given-names></name><name><surname>Heger</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>A</given-names></name><name><surname>Forsius</surname><given-names>H</given-names></name><name><surname>Jarvela</surname><given-names>I</given-names></name></person-group><article-title>Association of LOXL1 gene with Finnish exfoliation syndrome patients.</article-title><source>J Hum Genet</source><year>2009</year><volume>54</volume><fpage>289</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">19343041</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramprasad</surname><given-names>VL</given-names></name><name><surname>George</surname><given-names>R</given-names></name><name><surname>Soumittra</surname><given-names>N</given-names></name><name><surname>Sharmila</surname><given-names>F</given-names></name><name><surname>Vijaya</surname><given-names>L</given-names></name><name><surname>Kumaramanickavel</surname><given-names>G</given-names></name></person-group><article-title>Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>318</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">18334947</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Gotoh</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name></person-group><article-title>Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>582</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18201684</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>F</given-names></name><name><surname>Sakurada</surname><given-names>Y</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Yamagata</surname><given-names>Z</given-names></name><name><surname>Iijima</surname><given-names>H</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name></person-group><article-title>Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1303</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18636115</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuse</surname><given-names>N</given-names></name><name><surname>Miyazawa</surname><given-names>A</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Mengkegale</surname><given-names>M</given-names></name><name><surname>Otomo</surname><given-names>T</given-names></name><name><surname>Nishida</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1338</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18648524</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Vithana</surname><given-names>EN</given-names></name><name><surname>Yong</surname><given-names>VH</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Mizoguchi</surname><given-names>T</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Aung</surname><given-names>T</given-names></name></person-group><article-title>Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3976</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18450598</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanito</surname><given-names>M</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Akahori</surname><given-names>M</given-names></name><name><surname>Kaidzu</surname><given-names>S</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Ohira</surname><given-names>A</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><article-title>LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1898</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">18958304</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>S</given-names></name><name><surname>Hitora-Takeshita</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Omi</surname><given-names>N</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Kinoshita</surname><given-names>S</given-names></name></person-group><article-title>LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1037</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18552979</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Ho</surname><given-names>SL</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Venkataraman</surname><given-names>D</given-names></name><name><surname>Pek</surname><given-names>DC</given-names></name><name><surname>Aung</surname><given-names>T</given-names></name><name><surname>Vithana</surname><given-names>EN</given-names></name></person-group><article-title>Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese.</article-title><source>Mol Vis</source><year>2009</year><volume>15</volume><fpage>1120</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19503743</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>PJ</given-names></name><name><surname>Buhrmann</surname><given-names>R</given-names></name><name><surname>Quigley</surname><given-names>HA</given-names></name><name><surname>Johnson</surname><given-names>GJ</given-names></name></person-group><article-title>The definition and classification of glaucoma in prevalence surveys.</article-title><source>Br J Ophthalmol</source><year>2002</year><volume>86</volume><fpage>238</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">11815354</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>YB</given-names></name><name><surname>Friedman</surname><given-names>DS</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name><name><surname>Wang</surname><given-names>FH</given-names></name><name><surname>Duan</surname><given-names>XR</given-names></name><name><surname>Yang</surname><given-names>XH</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><name><surname>Zhan</surname><given-names>SY</given-names></name><name><surname>Sun</surname><given-names>LP</given-names></name><name><surname>Wang</surname><given-names>NL</given-names></name></person-group><article-title>Rationale, design, methodology, and baseline data of a population-based study in rural China: the Handan Eye Study.</article-title><source>Ophthalmic Epidemiol</source><year>2009</year><volume>16</volume><fpage>115</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">19353400</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercaldo</surname><given-names>ND</given-names></name><name><surname>Lau</surname><given-names>KF</given-names></name><name><surname>Zhou</surname><given-names>XH</given-names></name></person-group><article-title>Confidence intervals for predictive values with an emphasis to case-control studies.</article-title><source>Stat Med</source><year>2007</year><volume>26</volume><fpage>2170</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16927452</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>NE</given-names></name></person-group><article-title>Sequential tests for the detection of linkage.</article-title><source>Am J Hum Genet</source><year>1955</year><volume>7</volume><fpage>277</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">13258560</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>WF</given-names></name><name><surname>Chiang</surname><given-names>SW</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Jia</surname><given-names>LY</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Geng</surname><given-names>YQ</given-names></name><name><surname>Tham</surname><given-names>CC</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name></person-group><article-title>Evaluation of LOXL1 polymorphisms in primary open-angle glaucoma in southern and northern Chinese.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>2381</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19098994</pub-id></mixed-citation></ref></ref-list></back></article>